Hongzheng Ren
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Extracellular Vesicles as Immunotherapeutic Mediators in Gastrointestinal Cancers and Diseases: From Mechanisms to Clinical Translation.
Journal: Clinical pharmacology and therapeutics
Published: December 20, 2025
Integrated Proteomics and Metabolomics Analysis Provides Insights into Metformin Down-regulating GLUL and SP1 to Inhibit Esophageal Squamous Cell Carcinoma Migration and Invasion.
Journal: Recent patents on anti-cancer drug discovery
Published: December 11, 2025
Multi-omics analysis reveals the mechanism of indirect hepatotoxicity of triptolide upon LPS stimulation.
Journal: Toxicology letters
Published: October 22, 2025
Mitigating Cancer Therapy-Related Cognitive Impairment by Targeted Activation of Undruggable Phosphatase.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 21, 2025
Multi-omics Analysis Uncovers TFRC/HMOX1-dependent Ferroptosis Mediating Celastrol's Anti-invasive/Metastatic Effects on Esophageal Squamous Cell Carcinoma.
Journal: Recent patents on anti-cancer drug discovery
Published: September 15, 2025
Tripterygium wilfordii attenuates acute lung injury by regulating the differentiation and function of myeloid-derived suppressor cells.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: September 08, 2025
Triptolide ameliorates LPS-induced acute lung injury in Balb/c mice through gut-lung axis-mediated regulation of bile acid metabolism and gut microbiota.
Journal: Scientific reports
Published: August 11, 2025
Circulating extracellular vesicle PTPRO methylation: an exploratory biomarker for minimally invasive diagnosis of early-stage lung adenocarcinoma.
Journal: Cancer cell international
Published: May 28, 2025
Sex-based responses to immunotherapy in esophageal cancer: insights from a meta-analysis.
Journal: BMC gastroenterology
Published: April 30, 2025
Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer.
Journal: Cancer cell international
Published: April 16, 2025
Last Updated: 09/26/2026